PT - JOURNAL ARTICLE AU - Brassard, Didier AU - Presse, Nancy AU - Chevalier, Stéphanie TI - Estimating The Effect Of Adhering To Canada’s Food Guide 2019 Recommendations On Health Outcomes In Older Adults: A Target Trial Emulation Protocol AID - 10.1101/2024.05.29.24308054 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.29.24308054 4099 - http://medrxiv.org/content/early/2024/05/29/2024.05.29.24308054.short 4100 - http://medrxiv.org/content/early/2024/05/29/2024.05.29.24308054.full AB - Background The Canada’s Food Guide 2019 (CFG) provides universal recommendations to individuals aged 2 years or older. The extent to which these recommendations are appropriate for older adults is unknown. Although ideal, conducting a large randomized controlled trial is unrealistic in the short term. An alternative is the target trial emulation framework for causal inference using observational data.Objective Our aim is to describe the protocol of a target trial emulation in older adults with emphasis on key aspects of a hypothetical sustained diet and physical activity intervention.Methods To emulate the target trial, non-experimental data from the NuAge prospective study (n=1753, adults aged 67 years or older) will be used. NuAge includes 4 yearly measurements of dietary intakes, covariates and outcomes. The per protocol causal contrast will be the primary causal contrast of interest to account for non-adherence. The sustained intervention strategy will be modelled using the parametric g-formula. In the hypothetical trial, participants would be instructed to meet sex-specific minimal intakes for vegetables and fruits, whole grains, animal- and plant-based protein foods, milk & plant-based beverages and unsaturated fats. Eligibility criteria, follow-up, intervention, outcomes, and causal contrast will be similar in the emulation to the target trial except for minor modifications. We will attempt to emulate randomization of treatment by adjusting for baseline covariates and pre-baseline dietary habits.Conclusion Emulating a target trial will provide the first evidence of the adequacy of CFG 2019 recommendations for older adults in relation to health outcomes.Competing Interest StatementNancy Presse (NP) is the NuAge Database Administrator; NP and Stephanie Chevalier (SC) serve as NuAge Steering Committee Members.Funding StatementDidier Brassard (DB) holds a Canadian Institutes of Health Research (CIHR) Fellowship award (MFE-181852) to conduct the present study. This present study did not receive additional funding. The NuAge Study described in the present protocol was supported by a research grant from the Canadian Institutes of Health Research (CIHR; MOP-62842). The NuAge Database and Biobank are supported by the Fonds de recherche du Quebec (FRQ; 2020-VICO-279753), the Quebec Network for Research on Aging, a thematic network funded by the Fonds de Recherche du Quebec - Sante (FRQS) and by the Merck-Frosst Chair funded by La Fondation de l'Universite de Sherbrooke.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available simulated data that were originally located at: Health Canada. 2022. Simulated composite diets. Government Document, Open Government Portal. Available from https://open.canada.ca/data/en/dataset/0490749d-b0b0-410a-9577-a903c6cec2be.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data and code used for this manuscript will be made available at https://github.com/didierbrassard/NuAge_protocol